Agenus Secures 10 Million Loan from Zydus Backed by MiNK Therapeutics Shares

Reuters
10/10
Agenus Secures 10 Million Loan from Zydus Backed by MiNK <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Shares

Agenus Inc. has entered into a new Promissory Note Agreement with Zydus Pharmaceuticals $(USA)$ Inc., a subsidiary of Zydus Lifesciences Limited, for up to $10 million. The note, dated October 8, 2025, carries an interest rate of 3.81% per annum and will mature either upon the closing of an Asset Purchase Agreement and Securities Purchase Agreement between the companies or within 10 days of notification if the deals are not consummated. Proceeds from the loan will fund operational expenses for Agenus's Emeryville and Berkeley facilities in the fourth quarter of 2025, with amounts used for these expenses to be forgiven if the transactions close. As collateral, Agenus has pledged 822,910 shares of MiNK Therapeutics, Inc. common stock. The pledge and related control agreement grant certain rights to Zydus in the event of default, and the collateral is expected to be released upon repayment or forgiveness of the note.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-235819), on October 09, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10